Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

People with hair loss have different hormone levels, and these hormones can affect hair growth.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Women with androgenetic alopecia have lower SHBG levels.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A specific gene variation increases the risk of high uric acid and cholesterol in young Mexican males.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

The ABCG2 gene variant increases the risk of high uric acid and cholesterol, especially in overweight or obese young Mexican males.

Gene variation affects prostate issues and hair loss.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

The androgen receptor gene doesn't affect women with recurrent spontaneous abortions, but having a mutant genotype might protect against it.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

Hair loss gene linked to prostate issues.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.